Through multi‐dataset integration and deep computational analysis, this study refines the understanding of TGFβ1+ Tregs in CRC immune suppression and identifies potential therapeutic targets, offering new directions for precision immunotherapy. The gene discussed is TGFB1; the disease is colorectal carcinoma.